Press release
The Growing Influence Of Personalized Medicine In The Market: A Key Driver Powering Adrenogenital Syndrome Treatment Market Growth In 2025
Adrenogenital Syndrome Treatment
What Is the Current Adrenogenital Syndrome Treatment Market Size and Its Estimated Growth Rate?
Growth in the adrenogenital syndrome treatment market has been robust in the past years, and this upwards trend will continue. The market size, currently at $12.08 billion in 2024, is projected to see an increase to $12.84 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The market's expansion in the former period can be ascribed to factors like better awareness of less common diseases, an escalating pediatric population size, improvements in clinical awareness and education, surging occurrences of hormonal disorders, and increased access to medical services.
In the coming years, the adrenogenital syndrome treatment market size is anticipated to experience robust growth, reaching $16.19 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. The expected growth in this period can be credited to advanced genetic research, an increase in the patient base, a surge in targeted therapy adoption, improvement in healTH*Care infrastructure in developing markets, and enhanced government financing for treating rare diseases. Major trends during the predicted period encompass the rise of personalized medicine, the integration of gene therapy applications, the use of digital healTH*Care tools, advancements in non-invasive diagnostic methods, and collaborations between pharmaceutical firms and research institutes.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21086
How Are Emerging Segments Shaping the Adrenogenital Syndrome Treatment Market Landscape?
The adrenogenital syndrome treatment market covered in this report is segmented -
1) By Drug Type: Mineralocorticoids, Glucocorticoids
2) By Route of Administration: Oral, Parenteral, Intravenous, Inhaled
3) By Technology: Genetic Testing Technologies, Hormone Replacement Therapies, Surgical Technologies
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End-User: Hospitals, Clinics, Home Care Settings
Subsegments:
1) By Mineralocorticoids: Fludrocortisone, Other Mineralocorticoids
2) By Glucocorticoids: Hydrocortisone, Prednisolone, Dexamethasone, Other Glucocorticoids
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21086&type=smp
Which Growth Factors Are Influencing Adrenogenital Syndrome Treatment Market Expansion?
The adrenogenital syndrome treatment market is projected to flourish due to the rising usage of personalized medicines. These treatments are tailored to meet specific genetic makeup, lifestyle, and healTH*Care requirements of an individual, thereby enhancing their safety and effectiveness. Personalized medicines are gaining popularity due to progress in genetic science, heightened patient demand for bespoke treatments, and advancements in medical technology. Individual-specific genetic profiles and hormone levels are used in creating personalized treatments for adrenogenital syndrome, ensuring optimized effectiveness while reducing side effects. The Personalized Medicine Coalition, a USA-based non-profit body. reported FDA approvals for such treatments increased to 16 in 2023 from six in 2022, which included seven approvals for cancer and three for other conditions. Thus, the escalating usage of personalized medicines is set to bolster the growth of the adrenogenital syndrome treatment market.
Who Are the Dominant Players Across Different Adrenogenital Syndrome Treatment Market Segments?
Major companies operating in the adrenogenital syndrome treatment market are Pfizer Inc., Thermo Fisher Scientific, Novartis AG, Teva Pharmaceutical Industries Ltd., Lundbeck A/S, Neurocrine Biosciences Inc., Sandoz Group AG, IP Group Plc, BridgeBio Pharma, Bristol Laboratories Ltd, Changi General Hospital Pte Ltd, OMass Therapeutics, Spruce Biosciences Inc., Axplora, Diurnal Ltd., Alder Biopharmaceuticals Inc, Adrenas Therapeutics Inc, Crinetics Pharmaceuticals Inc., EffRx Pharmaceuticals, Millendo Therapeutics Inc.
What Are the Latest Developing Trends in the Adrenogenital Syndrome Treatment Market?
Key players in the adrenogenital syndrome treatment market are striving to create advanced remedies such as groundbreaking orphan drugs to fulfill unfulfilled healTH*Care needs, enhance patient results, and grow their market footprint by providing specialized treatments for uncommon and intricate conditions. Orphan drugs, designed to tackle rare and often serious diseases that impact a minimal number of patients, typically have limited or non-existent treatment alternatives. For example, in December 2024, Neurocrine Biosciences, a biotech firm based in the United States, declared that it had gained approval from the U.S. Food and Drug Administration (FDA) for CRENESSITY (crinecerfont), a novel treatment designed for children and adults who suffer from classic Congenital Adrenal Hyperplasia (CAH), a form of adrenogenital syndrome. The approval constitutes a significant landmark, offering the first new therapeutic alternative for CAH in seven decades and filling a pivotal void in the treatment of this unique endocrine disorder.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/adrenogenital-syndrome-treatment-global-market-report
Which Geographic Regions Are Expected to Dominate the Adrenogenital Syndrome Treatment Market in the Coming Years?
North America was the largest region in the adrenogenital syndrome treatment market in 2024. The regions covered in the adrenogenital syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Adrenogenital Syndrome Treatment Market?
2. What is the CAGR expected in the Adrenogenital Syndrome Treatment Market?
3. What Are the Key Innovations Transforming the Adrenogenital Syndrome Treatment Industry?
4. Which Region Is Leading the Adrenogenital Syndrome Treatment Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Growing Influence Of Personalized Medicine In The Market: A Key Driver Powering Adrenogenital Syndrome Treatment Market Growth In 2025 here
News-ID: 4069930 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Adrenogenital
Prominent Adrenogenital Syndrome Treatment Market Trend for 2025: Innovative Orp …
Which drivers are expected to have the greatest impact on the over the adrenogenital syndrome treatment market's growth?
The increasing adoption of personalized medicine is expected to contribute to the growth of the adrenogenital syndrome treatment market. Personalized medicine involves tailoring treatments to an individual's genetic composition, lifestyle, and health needs to enhance effectiveness and safety. The rising adoption of personalized medicine is attributed to advancements in genetics, growing patient demand…
Adrenogenital Syndrome Treatment Market Poised to Reach USD 19.4 Billion by 2031 …
Introduction
Adrenogenital Syndrome (AGS), also known as congenital adrenal hyperplasia (CAH), is a group of genetic disorders affecting the adrenal glands, leading to the abnormal production of steroid hormones. The growing prevalence of AGS, advancements in treatment options, and increasing awareness among patients and healthcare providers are key factors driving the expansion of the global Adrenogenital Syndrome Treatment Market.
With the market expected to reach USD 19.4 billion by 2031, this…
Adrenogenital Syndrome Treatment Market Forecast to Reach USD 19.4 Billion by 20 …
The global Adrenogenital Syndrome (AGS) treatment market is projected to reach a value of USD 19.4 billion by 2031, expanding at a robust CAGR during the forecast period. Adrenogenital Syndrome, also known as Congenital Adrenal Hyperplasia (CAH), is a rare genetic condition affecting the adrenal glands. Advances in medical research, improved diagnosis rates, and growing awareness about the condition are key factors driving the growth of this market.
This article explores…
Adrenogenital Syndrome Treatment Market Set for Robust Growth, Projected to Expa …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Adrenogenital Syndrome (AGS), often referred to as congenital adrenal hyperplasia (CAH), is a genetic disorder that affects the adrenal glands, leading to an imbalance in hormone production. This rare yet impactful condition results in various health complications, particularly related to sexual development, reproductive health, and growth patterns. AGS can be present from birth and varies in severity, depending on the type and cause.
As the global healthcare landscape continues to…
Global Veterinary Lasers Industry Poised for Remarkable Growth, Projected to Rea …
The global veterinary lasers industry is experiencing a period of unprecedented growth, fueled by groundbreaking technological advancements and a growing preference for minimally invasive procedures in animal healthcare.
According to a recent industry report, the market, valued at USD 205.8 million in 2023, is expected to surge to USD 505.4 million by 2033, with an impressive Compound Annual Growth Rate (CAGR) of 9.4% over the next decade.
This remarkable growth marks…
Adrenogenital Syndrome Treatment Market: Breakthrough Innovations and Evolving T …
𝑰𝒏𝒕𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏:
The Adrenogenital Syndrome (AGS), a disorder involving the adrenal glands, significantly impacts the hormonal regulation in the body, resulting in various health complications. As the demand for more precise and personalized treatments increases, the Adrenogenital Syndrome Treatment Market has evolved dramatically in recent years. Advancements in genetic research, new therapeutic modalities, and greater understanding of AGS's pathophysiology are shaping the future of patient care.
The global Adrenogenital Syndrome treatment market is…
